A DAD’S debilitating symptoms were repeatedly dismissed as “vertigo” by doctors. But Marcus Williams, 35, was given just ...

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

NEW YORK - IN8bio, Inc. (NASDAQ:INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies, reported ...

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...

Dr. Waqqas Tai is a cancer doctor who often shares health advice online. He recently revealed what the five most "lethal" ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...

When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient health should be considered.

Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...

BofA initiated coverage of Candel Therapeutics (CADL) with a Buy rating and $15 price target Candel’s pipeline includes two lead drugs – ...

RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...

Abstract: Glioma survival risk prediction is of great significance for the individualized treatment and assessment programs. Currently, most deep learning based survival prediction paradigms rely on ...